Prognostic significance of lymphovascular invasion in clinically localized prostate cancer after radical prostatectomy

被引:26
|
作者
Baydar, Dilek Ertoy [1 ]
Baseskioglu, Barbaros [2 ]
Ozen, Haluk [2 ]
Geyik, Pinar Ozdemir [3 ]
机构
[1] Hacettepe Univ, Sch Med, Dept Pathol, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Sch Med, Dept Urol, TR-06100 Ankara, Turkey
[3] Hacettepe Univ, Dept Biostat, Sch Med, TR-06100 Ankara, Turkey
来源
关键词
prostate adenocarcinoma; lymphovascular invasion; prognosis;
D O I
10.1100/tsw.2008.49
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Whether lymphovascular invasion (LVI) is an independent prognostic factor in prostate cancer is still controversial. We retrospectively investigated its predictive role in disease progression following radical prostatectomy. The histological sections of radical prostatectomies from 71 clinically localized, prostatic adenocarcinoma patients were reviewed for LVI. Pre- and postoperative follow-up data were collected. LVI was identified in 15.5% of cases. Univariate analysis showed a significant association between LVI and advanced pathological stage, higher Gleason score, positive surgical margins, extraprostatic extension, seminal vesicle invasion, and lymph node metastasis (each p < 0.05). Multivariate analyses pointed to vascular involvement as a strong and independent predictor for PSA failure (p = 0.023), and reduced biochemical progression-free survival (p = 0.019). LVI in radical prostatectomy is an adverse prognostic finding that must be recorded in the pathology report.
引用
收藏
页码:303 / 312
页数:10
相关论文
共 50 条
  • [41] Management of clinically localized prostate cancer by radical prostatectomy followed by watchful waiting
    Roger Kirby
    Nature Clinical Practice Urology, 2005, 2 : 298 - 303
  • [42] The impact of statins use in clinically localized prostate cancer treated with radical prostatectomy
    Rijo Mora, Enrique
    Lorente Garin, Jose A.
    Bielsa Gali, Oscar
    Frances Comalat, Albert
    Fumado Ciutat, Lluis
    Arango Toro, Octavio
    ACTAS UROLOGICAS ESPANOLAS, 2009, 33 (04): : 351 - 355
  • [43] Management of clinically localized prostate cancer by radical prostatectomy followed by watchful waiting
    Kirby, R
    NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (06): : 298 - 303
  • [44] Prognostic classifier for predicting biochemical recurrence in localized prostate cancer patients after radical prostatectomy
    Carrion, Albert
    Ingelmo-Torres, Mercedes
    Lozano, Juan Jose
    Montalbo, Ruth
    D'Anna, Maurizio
    Mercader, Claudia
    Velez, Elena
    Ribal, Maria Jose
    Alcaraz, Antonio
    Mengual, Lourdes
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (08) : 493.e17 - 493.e25
  • [45] Prognostic Importance of Lymphovascular Invasion for Specific Subgroup of Patients with Prostate Cancer After Robot-Assisted Radical Prostatectomy (The MSUG94 Group)
    Kawase, Makoto
    Ebara, Shin
    Tatenuma, Tomoyuki
    Sasaki, Takeshi
    Ikehata, Yoshinori
    Nakayama, Akinori
    Toide, Masahiro
    Yoneda, Tatsuaki
    Sakaguchi, Kazushige
    Teishima, Jun
    Makiyama, Kazuhide
    Inoue, Takahiro
    Kitamura, Hiroshi
    Saito, Kazutaka
    Koga, Fumitaka
    Urakami, Shinji
    Koie, Takuya
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (3) : 2154 - 2162
  • [46] Prognostic Importance of Lymphovascular Invasion for Specific Subgroup of Patients with Prostate Cancer After Robot-Assisted Radical Prostatectomy (The MSUG94 Group)
    Makoto Kawase
    Shin Ebara
    Tomoyuki Tatenuma
    Takeshi Sasaki
    Yoshinori Ikehata
    Akinori Nakayama
    Masahiro Toide
    Tatsuaki Yoneda
    Kazushige Sakaguchi
    Jun Teishima
    Kazuhide Makiyama
    Takahiro Inoue
    Hiroshi Kitamura
    Kazutaka Saito
    Fumitaka Koga
    Shinji Urakami
    Takuya Koie
    Annals of Surgical Oncology, 2024, 31 : 2154 - 2162
  • [47] Association of ERG/PTEN status with biochemical recurrence after radical prostatectomy for clinically localized prostate cancer
    Rohit Mehra
    Simpa S. Salami
    Robert Lonigro
    Ritu Bhalla
    Javed Siddiqui
    Xuhong Cao
    Daniel E. Spratt
    Ganesh S. Palapattu
    Nallasivam Palanisamy
    John T. Wei
    Arul M. Chinnaiyan
    Scott A. Tomlins
    Medical Oncology, 2018, 35
  • [48] Prognostic significance of Bcl-2 in clinically localized prostate cancer
    Bubendorf, L
    Sauter, G
    Moch, H
    Jordan, P
    Blochlinger, A
    Gasser, TC
    Mihatsch, MJ
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 148 (05): : 1557 - 1565
  • [49] Association of ERG/PTEN status with biochemical recurrence after radical prostatectomy for clinically localized prostate cancer
    Mehra, Rohit
    Salami, Simpa S.
    Lonigro, Robert
    Bhalla, Ritu
    Siddiqui, Javed
    Cao, Xuhong
    Spratt, Daniel E.
    Palapattu, Ganesh S.
    Palanisamy, Nallasivam
    Wei, John T.
    Chinnaiyan, Arul M.
    Tomlins, Scott A.
    MEDICAL ONCOLOGY, 2018, 35 (12)
  • [50] DNA Methylation Signatures for Prediction of Biochemical Recurrence After Radical Prostatectomy of Clinically Localized Prostate Cancer
    Haldrup, Christa
    Mundbjerg, Kamilla
    Vestergaard, Else Marie
    Lamy, Philippe
    Wild, Peter
    Schulz, Wolfgang A.
    Arsov, Christian
    Visakorpi, Tapio
    Borre, Michael
    Hoyer, Soren
    Orntoft, Torben F.
    Sorensen, Karina D.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26) : 3250 - +